Exact Mass: 340.1899

Exact Mass Matches: 340.1899

Found 103 metabolites which its exact mass value is equals to given mass value 340.1899, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pentamidine

American pharmaceutical partners brand 1 OF pentamidine isethionate

C19H24N4O2 (340.1899)


Pentamidine is only found in individuals that have used or taken this drug. It is an antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. [PubChem]The mode of action of pentamidine is not fully understood. It is thought that the drug interferes with nuclear metabolism producing inhibition of the synthesis of DNA, RNA, phospholipids, and proteins. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Mepenzolate

Mepenzolic acid, bromine salt, 1-(methyl-(14)C)-labeled

C21H26NO3+ (340.1913)


Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Methantheline

diethyl(methyl)[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium

C21H26NO3+ (340.1913)


Methantheline is a synthetic antispasmodic. Antispasmodics are used to relieve cramps or spasms of the stomach, intestines, and bladder. Methantheline is used to treat intestine or stomach ulcers (peptic ulcer disease), intestine problems (irritable bowel syndrome), pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, or urinary problems (reflex neurogenic bladder in children). A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Perindoprilat

(2S,3aS,7aS)-1-[(2S)-2-{[(1S)-1-carboxybutyl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid

C17H28N2O5 (340.1998)


Perindoprilat is a metabolite of perindopril. Perindopril, or perindopril arginine, (trade names include Coversyl and Aceon) is a long-acting ACE inhibitor. Perindopril is used to treat high blood pressure, heart failure or stable coronary artery disease. It is also available in a generic form, perindopril erbumine. (Wikipedia) D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

pentamidine

pentamidine

C19H24N4O2 (340.1899)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent [Raw Data] CB201_Pentamidine_pos_50eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_40eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_30eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_20eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_10eV_isCID-10eV_rep000006.txt KEIO_ID P209; [MS2] KO009179 KEIO_ID P209; [MS3] KO009180 KEIO_ID P209

   

11-Dehydro-2,3-dinor-txb2

5-[4-hydroxy-2-(3-hydroxyoct-1-en-1-yl)-6-oxooxan-3-yl]pent-3-enoic acid

C18H28O6 (340.1886)


   

3-[2-(3-Guanidino-2-methyl-3-oxo-propenyl)-5-methyl-phenyl]-N-isopropylidene-2-methyl-acrylamide

N-(diaminomethylidene)-2-methyl-3-(4-methyl-2-{2-methyl-2-[(propan-2-ylidene)carbamoyl]eth-1-en-1-yl}phenyl)prop-2-enamide

C19H24N4O2 (340.1899)


   

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

C22H29OP (340.1956)


   

Glycyl-l-histidyl-l-lysine

6-amino-2-[[2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid

C14H24N6O4 (340.1859)


   

p-Hydroxyphenethyl anisate

p-Hydroxyphenethyl anisate

C21H26NO3 (340.1913)


   

Poldine

Poldine

C21H26NO3+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds

   

MCULE-3035603698

MCULE-3035603698

C18H28O6 (340.1886)


   

Egregiachloride A

Egregiachloride A

C19H29ClO3 (340.1805)


   
   

gamahonolide B

gamahonolide B

C18H28O6 (340.1886)


   

alpha-o-methylbotrydialone|alpha-O-methyldihydrobotrydialone

alpha-o-methylbotrydialone|alpha-O-methyldihydrobotrydialone

C18H28O6 (340.1886)


   

1, 2:4, 5-Di-O-cyclohexylidene-beta-D-Pyranose-Fructose

1, 2:4, 5-Di-O-cyclohexylidene-beta-D-Pyranose-Fructose

C18H28O6 (340.1886)


   

Pestalotiopsin A

Pestalotiopsin A

C18H28O6 (340.1886)


   

11-dehydro-2,3-dinor Thromboxane B2

9α,15S-dihydroxy-11-oxo-2,3-dinor-thromba-5Z,13E-dien-1-oic acid

C18H28O6 (340.1886)


   

1beta,4beta-dihydroxy-8beta-acetoxy-5alphaH-eudesma-11(13)-en-12-oic acid methyl ester

1beta,4beta-dihydroxy-8beta-acetoxy-5alphaH-eudesma-11(13)-en-12-oic acid methyl ester

C18H28O6 (340.1886)


   

1,2:5,6-di-o-cyclohexylidene-myo-inositol

1,2:5,6-di-o-cyclohexylidene-myo-inositol

C18H28O6 (340.1886)


   

5-Ac,Me ether-4,5,10-Trihydroxy-11(13)-amorphen-12-oic acid|methyl 5-acetoxy-4,5-dihydro-4,10-dihydroxy-5-acetoxyartemisinate

5-Ac,Me ether-4,5,10-Trihydroxy-11(13)-amorphen-12-oic acid|methyl 5-acetoxy-4,5-dihydro-4,10-dihydroxy-5-acetoxyartemisinate

C18H28O6 (340.1886)


   

methyl acetylbotryaloate

methyl acetylbotryaloate

C18H28O6 (340.1886)


   
   
   

Copper Peptide(GHK-Cu, GHK-Copper)

Copper Peptide(GHK-Cu, GHK-Copper)

C14H24N6O4 (340.1859)


   

Poldine

Poldine

[C21H26NO3]+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds

   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

NCGC00347635-02![5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

C18H28O6 (340.1886)


   
   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

C18H28O6 (340.1886)


   
   

Perindoprilat

Perindoprilat (diacid form)

C17H28N2O5 (340.1998)


A dipeptide obtained by formal condensation of one of the carboxy groups of N-[(1S)-1-carboxyethyl]-L-norvaline with the amino group of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid. The major active metabolite of perindopril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based on: CCMSLIB00000848998]

NCGC00347635-02![5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based on: CCMSLIB00000848998]

C18H28O6 (340.1886)


   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based: Match]

NCGC00347635-02![5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based: Match]

C18H28O6 (340.1886)


   
   
   
   
   
   

2,3-Dinor-6-keto-PGF1a

2,3-Dinor-6-keto-PGF1a

C18H28O6 (340.1886)


   

11-dehydro-2,3-dinor-TXB2

2,3-dinor-9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid

C18H28O6 (340.1886)


   

methantheline

Banthine Bromide;Methantheline Bromide;Methanthelinium;Methanthelinium Bromide;Methanthelinum;Methanthine Bromide;MTB 51

C21H26NO3+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

FA 18:4;O4

2,3-dinor-9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid

C18H28O6 (340.1886)


   

Copper Peptide

Glycyl-l-histidyl-l-lysine

C14H24N6O4 (340.1859)


Glycyl-L-histidyl-L-lysine is a tripeptide consisting of glycine, L-histidine and L-lysine residues joined in sequence. Glycyl-L-histidyl-L-lysine is a hepatotropic immunosuppressor and shows anxiolytic effect. Glycyl-L-histidyl-L-lysine and its copper complexes show good skin tolerance[1][2][3].

   

1,2:5,6-DI-O-CYCLOHEXYLIDENE-3-CYANO-ALPHA-D-ALLOFURANOSE

1,2:5,6-DI-O-CYCLOHEXYLIDENE-3-CYANO-ALPHA-D-ALLOFURANOSE

C18H28O6 (340.1886)


   

2-(4-(BENZYLOXY)-3-METHOXYPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

2-(4-(BENZYLOXY)-3-METHOXYPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C20H25BO4 (340.1846)


   

1,2:5,6-Di-O-cyclohexylidene-alpha-D-glucofuranose

1,2:5,6-Di-O-cyclohexylidene-alpha-D-glucofuranose

C18H28O6 (340.1886)


   

(3R)-1-(3-CHLOROPYRIDIN-2-YL)-3-METHYLPIPERAZINE

(3R)-1-(3-CHLOROPYRIDIN-2-YL)-3-METHYLPIPERAZINE

C21H28O2Si (340.1858)


   

3-Fluorophenyl 4-trans-propylcyclohexylbenzoate

3-Fluorophenyl 4-trans-propylcyclohexylbenzoate

C22H25FO2 (340.1838)


   

9-Acridineethanamine,N-(1-methyl-2-phenylethyl)-

9-Acridineethanamine,N-(1-methyl-2-phenylethyl)-

C24H24N2 (340.1939)


   

[6-(4-methyl-piperazin-1-yl)-4-o-tolylpyridin-3-yl]-carbamic acid methyl ester

[6-(4-methyl-piperazin-1-yl)-4-o-tolylpyridin-3-yl]-carbamic acid methyl ester

C19H24N4O2 (340.1899)


   

CarboxyMethylcellulose sodiuM

CarboxyMethylcellulose sodiuM

C19H24N4O2 (340.1899)


   

(2S)-5-(tert-butyldiphenylsilyloxy)-1,2-epoxypentane

(2S)-5-(tert-butyldiphenylsilyloxy)-1,2-epoxypentane

C21H28O2Si (340.1858)


   

4-Chloro-4-(trans-4-pentylcyclohexyl)-1,1-biphenyl

4-Chloro-4-(trans-4-pentylcyclohexyl)-1,1-biphenyl

C23H29Cl (340.1958)


   

2,3:5,6-DI-O-CYCLOHEXYLIDENE-ALPHA-D-MANNOFURANOSE

2,3:5,6-DI-O-CYCLOHEXYLIDENE-ALPHA-D-MANNOFURANOSE

C18H28O6 (340.1886)


   

4,4-Methylenebis(1,1-dimethyl-3-phenylurea)

4,4-Methylenebis(1,1-dimethyl-3-phenylurea)

C19H24N4O2 (340.1899)


   

Penthienate

Penthienate

C18H30NO3S+ (340.1946)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds

   

Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-

Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-

C22H29OP (340.1956)


   

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

C22H29OP (340.1956)


   

1-[2-(3,4-dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine

1-[2-(3,4-dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine

C21H25FN2O (340.1951)


   

Parapenzolate

Parapenzolate

C21H26NO3+ (340.1913)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

L-Histidine, N-(N(2)-glycyl-L-lysyl)-

L-Histidine, N-(N(2)-glycyl-L-lysyl)-

C14H24N6O4 (340.1859)


   
   

L-Lysine, N2-(N-L-histidylglycyl)-

L-Lysine, N2-(N-L-histidylglycyl)-

C14H24N6O4 (340.1859)


   

DES(2-methylbutanoyl)pravastatin

DES(2-methylbutanoyl)pravastatin

C18H28O6 (340.1886)


   

(E)-N-(diaminomethylidene)-2-methyl-3-[4-methyl-2-[(E)-2-methyl-3-oxo-3-(propan-2-ylideneamino)prop-1-enyl]phenyl]prop-2-enamide

(E)-N-(diaminomethylidene)-2-methyl-3-[4-methyl-2-[(E)-2-methyl-3-oxo-3-(propan-2-ylideneamino)prop-1-enyl]phenyl]prop-2-enamide

C19H24N4O2 (340.1899)


   

(E)-5-[4-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-6-oxooxan-3-yl]pent-3-enoic acid

(E)-5-[4-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-6-oxooxan-3-yl]pent-3-enoic acid

C18H28O6 (340.1886)


   
   

6-[2-(Dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile

6-[2-(Dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile

C19H24N4O2 (340.1899)


   

Glycine, N-(N2-L-histidyl-L-lysyl)-

Glycine, N-(N2-L-histidyl-L-lysyl)-

C14H24N6O4 (340.1859)


   

(11S)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

(11S)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

C19H24N4O2 (340.1899)


   

(11R)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

(11R)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

C19H24N4O2 (340.1899)


   

mepenzolate

mepenzolate

C21H26NO3+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Gly-His-Lys

Gly-His-Lys

C14H24N6O4 (340.1859)


A tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence.

   

6-amino-2-[[2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid

6-amino-2-[[2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid

C14H24N6O4 (340.1859)


   

Dehydro-dinor-TXB2

Dehydro-dinor-TXB2

C18H28O6 (340.1886)


   
   
   
   
   

8-hydroxy-2-(1-hydroxyheptyl)-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

8-hydroxy-2-(1-hydroxyheptyl)-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

C18H28O6 (340.1886)


   

(1r,4s,7r,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

(1r,4s,7r,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

C18H28O6 (340.1886)


   

(1r,4s,7s,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

(1r,4s,7s,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

C18H28O6 (340.1886)


   

methyl 2-[(2r,3r,4ar,5r,8r,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

methyl 2-[(2r,3r,4ar,5r,8r,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

C18H28O6 (340.1886)


   

(1s,2s,4z,6r,7r,8s,9r,13r)-6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

(1s,2s,4z,6r,7r,8s,9r,13r)-6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

methyl 4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

methyl 4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

C18H28O6 (340.1886)


   

12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

C18H28O6 (340.1886)


   

methyl 2-[8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

methyl 2-[8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

C18H28O6 (340.1886)


   

(1s,4r,5s,6r,7r,8s,9r,11s,13s)-6,9-dihydroxy-7-methoxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-11-yl acetate

(1s,4r,5s,6r,7r,8s,9r,11s,13s)-6,9-dihydroxy-7-methoxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-11-yl acetate

C18H28O6 (340.1886)


   

methyl 2-[3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

methyl 2-[3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

C18H28O6 (340.1886)


   

(3z,4r,5s,6s,7r)-3-decylidene-4,5,6,7-tetrahydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one

(3z,4r,5s,6s,7r)-3-decylidene-4,5,6,7-tetrahydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one

C18H28O6 (340.1886)


   

1-(4-hydroxy-1,3-dihydro-2-benzofuran-1-yl)decane-2,3,4,5-tetrol

1-(4-hydroxy-1,3-dihydro-2-benzofuran-1-yl)decane-2,3,4,5-tetrol

C18H28O6 (340.1886)


   

(2s,4r,8r)-8-hydroxy-2-[(1s)-1-hydroxyheptyl]-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

(2s,4r,8r)-8-hydroxy-2-[(1s)-1-hydroxyheptyl]-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

C18H28O6 (340.1886)


   

methyl 2-[(1r,4s,4ar,7r,8r,8ar)-8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

methyl 2-[(1r,4s,4ar,7r,8r,8ar)-8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

C18H28O6 (340.1886)


   

1-ethyl 4-(2r)-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]heptan-2-yl butanedioate

1-ethyl 4-(2r)-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]heptan-2-yl butanedioate

C18H28O6 (340.1886)


   

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl hexa-2,4-dienoate

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl hexa-2,4-dienoate

C18H28O6 (340.1886)


   

methyl (1s,3ar,4s,6r,7s,7as)-4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

methyl (1s,3ar,4s,6r,7s,7as)-4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

C18H28O6 (340.1886)


   

(1s,2s,4e,6r,7r,9r,13r)-7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

(1s,2s,4e,6r,7r,9r,13r)-7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

1-ethyl 4-[7-(6-oxo-2,3-dihydropyran-2-yl)heptan-2-yl] butanedioate

1-ethyl 4-[7-(6-oxo-2,3-dihydropyran-2-yl)heptan-2-yl] butanedioate

C18H28O6 (340.1886)


   

methyl 2-[(2r,3r,4ar,5r,8s,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

methyl 2-[(2r,3r,4ar,5r,8s,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

C18H28O6 (340.1886)


   

6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl (2e,4e)-hexa-2,4-dienoate

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl (2e,4e)-hexa-2,4-dienoate

C18H28O6 (340.1886)